Antihypertensive (2-aminoethyl)thiourea derivatives. 1

|December 1, 1980

Abstract:

Structure-activity studies were carried out on a series of antihypertensive 1-(2-aminoethyl)-3-(substituted phenyl)thioureas. From this class of compounds, the 2,6-dichlorophenyl analogue 2 was found to have potent oral antihypertensive activity in two hypertensive rat models and the renal hypertensive dog. In addition to its effect on blood pressure, 2 displayed sedative effects which had a marked species specificity.

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Generation of an LFA-1 antagonist by the transfer of the ICAM-1 immunoregulatory epitope to a small molecule.

Science (New York, N.Y.)·2002

Imide and lactam derivatives of N-benzylpyroglutamyl-L-phenylalanine as VCAM/VLA-4 antagonists.

Bioorganic & medicinal chemistry letters·2001

The design and synthesis of potent cyclic peptide VCAM-VLA-4 antagonists incorporating an achiral Asp-Pro mimetic.

Bioorganic & medicinal chemistry letters·2000

Cyclic thioether peptide mimetics as VCAM-VLA-4 antagonists.

Bioorganic & medicinal chemistry letters·2000

N-acyl phenylalanine analogues as potent small molecule VLA-4 antagonists.

Bioorganic & medicinal chemistry letters·2000

N-benzylpyroglutamyl-L-phenylalanine derivatives as VCAM/VLA-4 antagonists.

Bioorganic & medicinal chemistry letters·2000

See all related articles

Related Experiment Videos

Antihypertensive (2-aminoethyl)thiourea derivatives. 1

Related Concept Videos

Generation of an LFA-1 antagonist by the transfer of the ICAM-1 immunoregulatory epitope to a small molecule.

Imide and lactam derivatives of N-benzylpyroglutamyl-L-phenylalanine as VCAM/VLA-4 antagonists.

The design and synthesis of potent cyclic peptide VCAM-VLA-4 antagonists incorporating an achiral Asp-Pro mimetic.

Cyclic thioether peptide mimetics as VCAM-VLA-4 antagonists.

N-acyl phenylalanine analogues as potent small molecule VLA-4 antagonists.

N-benzylpyroglutamyl-L-phenylalanine derivatives as VCAM/VLA-4 antagonists.

Discovery of Monoterpenoid Indole Alkaloids Targeting CCN1 to Suppress Autophagy for the Treatment of Hypoxic Kidney Injury.

Selective Macrocyclic WEE1 Kinase Inhibitors with Strong Efficacy against Patient-Derived Colorectal Cancer Organoids.

Neutral Backbone Modifications Enhance the Pharmacokinetics and Biodistribution of Antibody-Oligonucleotide Conjugates with High Drug-to-Antibody Ratios.

Discovery of TL10: A Soluble and Long-Acting MC4R Agonist with Tunable Lipidation for Sustained Pharmacological Activity.

Discovery, Synthesis, and Biological Evaluation of 1,3,4,5-Tetrahydro-6H-pyrano[4,3-c]isoquinolin-6-one Derivatives as Novel and Highly Selective PARP1 Inhibitors.

Discovery and Optimization of Novel Nonhydroxamate LpxC Inhibitors for the Treatment of Multidrug-Resistant Gram-Negative Infections.

Molecular logics in dual sensor regulation of diguanylate cyclase activity-Phosphorylation OR blue-light activation.

Serendipitous Emergence of Pyrrolo[2,3,4-kl]acridin-1(2H)-one Derivatives: From Unexpected Discovery to Synthetic Development.

SmI2-mediated tandem cyclization route for stereoselective synthesis of the tetracyclic core of daphenylline.

Arylsulfonylaminopyridines as Potential Epac Inhibitors: Design, Synthesis and Effects on Myocardial Strips.

Recent Comparative Advances in the Mechanistic Actions and Translational Relevance of Syringic Acid and Vanillic Acid for Oxidative Stress-Associated Disorders.

Herbal Creams in Dermatology: Efficacy, Safety, Formulation, and Regulatory Considerations.

Related Experiment Videos

Antihypertensive (2-aminoethyl)thiourea derivatives. 1

Abstract:

Related Concept Videos

Related Articles